Over the past 4-5 years, there has been a rapid increase in the studies and articles on cardiac CT angiography (CCTA). For 15 years prior to this, many of the early articles primarily focused on the use of CT for coronary calcium scoring for early identification of patients at risk for coronary artery disease and cardiac events along with the benefits of preventative therapies. More recently, with the introduction of artificial intelligence (AI) tools, CCTA is making its way to the top of the list of the tools being used by cardiologists for prognosis and treatment of patients with coronary artery disease. CCTA w/ fractional flow reserve (FFRCT) is now supporting interventional cardiologists in pre-procedure planning 1 thus increasing revascularizations rates among patients referred for elective ICA.11
A consensus document that was published by the Society of Cardiac Computed Tomography and North American Society of Cardiovascular Imaging states that CCTA provides a wealth of clinically meaning information beyond anatomic stenosis, including the presence and absence of nonobstructive atherosclerosis and high-risk plague features being precursors for incident of coronary artery disease.2
The article, “Pre-Procedural Planning of Coronary Revascularization by Cardiac Computed Tomography,” published in the Journal of Cardiovascular Computed Tomography (JCCT), states that CCTA combined with fractional flow reserve (CT-FFR) or stress CT myocardial perfusion imaging (CT-MPI) can overcome the limitations of two-dimensional invasive coronary angiography (ICA) by providing a comprehensive anatomical and physiological roadmap for coronary revascularization. Additionally, the consensus document published by the Society of Cardiac Computed Tomography, co-published with Eurointervention, explains that CCT may emerge in the field of interventional cardiology as no longer “a mere diagnostic tool,” as it was when first introduced into clinical practice more than 15 years ago.
According to the writing group, led by Daniele Andreini, MD, PhD, FSCCT of Centro Cardiologico Monzino in Milan, Italy, the potential value of CCTA to plan and guide interventional procedures lies in the wide information it can provide, including its accuracy for plaque and calcium characterization. With the additional information used to assess the coronary artery anatomy, the number of patients referred to the catheterization lab is expected to increase over the next decade.1
Andreini and his co-authors explain that, with its 3-dimensional nature and physiological assessment, CCTA is the only non-invasive imaging modality to assess Syntax Score and Syntax Score II, which enable the Heart Team to select the mode of revascularization (PCI or CABG) for patients with complex disease based on long-term mortality.
When these tools are utilized for diagnosis and treatment planning, patients’ care is tailored more specifically for early medical or invasive interventions. An abstract presented at SCCT meeting in July 2023 by Wesley T. O’Neal, MD, et al. on data collected on patients from Cone Health Heart and Vascular Center, showed the benefits for diagnosis and treatment from implementation of CCTA/FFRCT program. A robust program increased revascularization to invasive coronary angiography (ICA) rates among patients referred for elective ICA, thus improving catheterization laboratory utilization. The abstract shown in Table 1, shows that while the number of elective revascularization procedures remained similar during the study period, 2018-2022, the ratio of revascularization to ICA increased by 21% for the same period.
The emerging articles show that the use of CCTA/FFRCT has a positive impact of appropriate patient selection for ICA and revascularization. Additionally, it allows for pre-planning of procedures and patient care, optimizing cardiac catheterization laboratory resources, workflows, and patient care.
Cardiac CT programs are changing the way that cardiologists diagnose and treat patients with potential for cardiac events. A robust CCTA program, combined with the tools provided by HeartFlow, Cleerly, Elucid Vivo, and Caristo, has substantial impact on our ability to appropriately impact patient care earlier and impact outcomes while supporting efficient use of catheterization laboratory and provider resources. A CCTA program that focuses on efficient workflows, optimal patient prep, along with necessary AI, will improve efficiencies for ICA programs.
Is your CCTA program providing maximum benefits for your cardiologists?
References
- Andreini, et al. Pre-procedural planning of coronary revascularization by cardiac computed tomography: An expert consensus document of the Society of Cardiovascular Computed Tomography. Journal of Cardiovascular Computed Tomography. Published November 2022>
- J. Shaw, et al. Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging – Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque. Journal of Cardiovascular Computed Tomography. Published March 2021
- O’Neal, et al. Impact of CCTA/FFRCT on Referrals for Invasive Coronary Angiography and Revascularization in a Community-based Health System. Presented Society of Cardiovascular Computed Tomography Meeting. July 2023
- https://scct.org/news/news.asp?id=615188&hhSearchTerms=%22CCTA+and+%2b+and+PCI%22